Literature DB >> 29984396

The comorbidity of acute ischemic stroke and splenic infarction resulting from essential thrombocythemia.

Junliang Yuan1, Yanhong Wu2, Jianyu Hao3, Wenli Hu4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29984396     DOI： 10.1007/s10072-018-3462-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  9 in total

1.  Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.

Authors:  Keun-Tae Kim; Sung-Il Sohn; Kyung-Hee Cho
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-02-03       Impact factor: 2.136

2.  Acquired hemophilia A in a patient with essential thrombocythemia.

Authors:  Naoki Mori; Kyoichi Totsuka; Noriko Ishimori; Kentaro Yoshinaga; Masanao Teramura; Sanshiro Noguchi; Hideaki Oda; Toshiko Motoji
Journal:  Acta Haematol       Date:  2012-02-01       Impact factor: 2.195

3.  Ischemic stroke with essential thrombocythemia: a case series.

Authors:  Yuji Kato; Takeshi Hayashi; Yoshihide Sehara; Ichiro Deguchi; Takuya Fukuoka; Hajime Maruyama; Yohsuke Horiuchi; Yuito Nagamine; Hiroyasu Sano; Norio Tanahashi
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-02-25       Impact factor: 2.136

Review 4.  Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

Authors:  A Tefferi; J W Vardiman
Journal:  Leukemia       Date:  2007-09-20       Impact factor: 11.528

5.  Multiple venous and arterial thromboses of the gallbladder causing acute cholecystitis. A previously undescribed complication of essential thrombocythemia.

Authors:  Gabriela Picón-Coronel; Fredy Chablé-Montero; Arturo Angeles-Ángeles; Jorge Albores-Saavedra
Journal:  Ann Hepatol       Date:  2011 Jul-Sep       Impact factor: 2.400

6.  Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.

Authors:  Sandra Malak; Myriam Labopin; Cecile Saint-Martin; Christine Bellanne-Chantelot; Albert Najman
Journal:  Blood Cells Mol Dis       Date:  2012-07-19       Impact factor: 3.039

Review 7.  What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

Authors:  Alessandro M Vannucchi; Paola Guglielmelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Stroke in essential thrombocythemia.

Authors:  Éva Pósfai; Imelda Marton; Anita Szőke; Zita Borbényi; László Vécsei; Angéla Csomor; Katalin Sas
Journal:  J Neurol Sci       Date:  2013-10-16       Impact factor: 3.181

Review 9.  Essential thrombocythemia treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037
  9 in total
  4 in total

1.  Splenic Infarct as the Presenting Manifestation of Essential Thrombocythemia.

Authors:  Shalaka Khade; Sudeep Khera; Vaibhav Kumar Varshney; Deepak Kumar Sharma; Raghav Nayar; Abhishek Purohit
Journal:  Ochsner J       Date:  2022

2.  Recurrent thrombosis of splanchnic and lower extremity arteries with essential thrombocythemia.

Authors:  Sung Min Jung; Heungman Jun
Journal:  SAGE Open Med Case Rep       Date:  2019-09-27

3.  Essential thrombocythemia with CALR mutation and recurrent stroke: two case reports and literature review.

Authors:  Rong Chen; Xiaodan Shi; Luojun Wang; Xuan Wang; Jingya Wei; Xiaogang Kang; Fang Du; Shan Gao; Fang Yang; Wen Jiang
Journal:  Ther Adv Neurol Disord       Date:  2022-04-26       Impact factor: 6.430

4.  Complex intracranial vascular complications caused by essential thrombocythemia: a critical case report.

Authors:  Jian Xie; Leiyu Geng; Baoyu Yuan; Yijing Guo; Zhijun Zhang
Journal:  BMC Neurol       Date:  2020-11-07       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.